Literature DB >> 11238052

Generation of C-reactive protein and complement components in atherosclerotic plaques.

K Yasojima1, C Schwab, E G McGeer, P L McGeer.   

Abstract

C-reactive protein (CRP) and complement are hypothesized to be major mediators of inflammation in atherosclerotic plaques. We used the reverse transcriptase-polymerase chain reaction technique to detect the mRNAs for CRP and the classical complement components C1 to C9 in both normal arterial and plaque tissue, establishing that they can be endogenously generated by arteries. When the CRP mRNA levels of plaque tissue, normal artery, and liver were compared in the same cases, plaque levels were 10.2-fold higher than normal artery and 7.2-fold higher than liver. By Western blotting, we showed that the protein levels of CRP and complement proteins were also up-regulated in plaque tissue and that there was full activation of the classical complement pathway. By in situ hybridization, we detected intense signals for CRP and C4 mRNAs in smooth muscle-like cells and macrophages in the thickened intima of plaques. By immunohistochemistry we showed co-localization of CRP and the membrane attack complex of complement. We also detected up-regulation in plaque tissue of the mRNAs for the macrophage markers CD11b and HLA-DR, as well as their protein products. We showed by immunohistochemistry macrophage infiltration of plaque tissue. Because CRP is a complement activator, and activated complement attacks cells in plaque tissue, these data provide evidence of a self-sustaining autotoxic mechanism operating within the plaques as a precursor to thrombotic events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238052      PMCID: PMC1850354          DOI: 10.1016/S0002-9440(10)64051-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

Review 1.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research.

Authors:  P Libby; D Egan; S Skarlatos
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

Review 2.  The myofibroblast: a quarter century after its discovery.

Authors:  W Schürch; T A Seemayer; G Gabbiani
Journal:  Am J Surg Pathol       Date:  1998-02       Impact factor: 6.394

Review 3.  Processes in atherogenesis: complement activation.

Authors:  J Torzewski; D E Bowyer; J Waltenberger; C Fitzsimmons
Journal:  Atherosclerosis       Date:  1997-07-25       Impact factor: 5.162

4.  Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

5.  Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion.

Authors:  M Torzewski; M Klouche; J Hock; M Messner; B Dorweiler; J Torzewski; H E Gabbert; S Bhakdi
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-03       Impact factor: 8.311

6.  C-reactive protein as a marker for acute coronary syndromes.

Authors:  F Mach; C Lovis; J M Gaspoz; P F Unger; M Bouillie; P Urban; W Rutishauser
Journal:  Eur Heart J       Date:  1997-12       Impact factor: 29.983

7.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

Authors:  P M Ridker; J E Buring; J Shih; M Matias; C H Hennekens
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

8.  C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

Authors:  D A Morrow; N Rifai; E M Antman; D L Weiner; C H McCabe; C P Cannon; E Braunwald
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

9.  C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.

Authors:  J Torzewski; M Torzewski; D E Bowyer; M Fröhlich; W Koenig; J Waltenberger; C Fitzsimmons; V Hombach
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-09       Impact factor: 8.311

10.  Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion.

Authors:  K Yasojima; K S Kilgore; R A Washington; B R Lucchesi; P L McGeer
Journal:  Circ Res       Date:  1998-06-15       Impact factor: 17.367

View more
  108 in total

Review 1.  Local neuroinflammation and the progression of Alzheimer's disease.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  C-reactive protein and risk of cardiovascular disease: evidence and clinical application.

Authors:  Paul M Ridker; Shari S Bassuk; Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 3.  The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis.

Authors:  Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

4.  Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

Authors:  Amit Saxena; Peter M Izmirly; Sung Won Han; Paraskevi Briassouli; Tania L Rivera; Hua Zhong; Deborah M Friedman; Robert M Clancy; Jill P Buyon
Journal:  J Am Coll Cardiol       Date:  2015-08-25       Impact factor: 24.094

5.  Preoperative C-reactive protein predicts long-term mortality and hospital length of stay after primary, nonemergent coronary artery bypass grafting.

Authors:  Tjörvi E Perry; Jochen D Muehlschlegel; Kuang-Yu Liu; Amanda A Fox; Charles D Collard; Simon C Body; Stanton K Shernan
Journal:  Anesthesiology       Date:  2010-03       Impact factor: 7.892

6.  Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins.

Authors:  D Skowasch; S Schrempf; C J Preusse; J A Likungu; A Welz; B Lüderitz; G Bauriedel
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 7.  Novel serologic markers of cardiovascular risk.

Authors:  Guilherme H M Oliveira
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

8.  Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study.

Authors:  J Jylhävä; C Eklund; T Pessi; O T Raitakari; M Juonala; M Kähönen; J S A Viikari; T Lehtimäki; M Hurme
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes.

Authors:  Uma Singh; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Clin Chem       Date:  2008-12-12       Impact factor: 8.327

Review 10.  The role of complement activation in atherosclerosis.

Authors:  Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.